NP-50301
NP-50301 Uses, Dosage, Side Effects, Food Interaction and all others data.
NP-50301 is an ophthalmic therapeutic eye drop treating post-menopausal Dry Eye Syndrome (DES). It is being developed by Nascent Pharmaceuticals. It is estimated that about 30% of postmenopausal women suffer symptoms of DES, which accounts for over 12 million women in the U.S. The majority of sufferers of DES are postmenopausal women; and clinical research around the world has suggested the benefits of both topical and systemic estrogen therapy in the treatment of DES in this population.
Trial results indicate that NP50301 therapy provides a benefit in relieving the signs and symptoms presented by DES in postmenopausal women. Importantly, there were no drug-related serious adverse events in the study.
| Trade Name | NP-50301 |
| Generic | NP-50301 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in eye disorders/infections.
How NP-50301 works
NP50301 is an estrogen ester compound believed to act by multiple mechanisms, including influencing the health of the cornea, the meibomian glands and the conjunctiva.
Innovators Monograph
You find simplified version here NP-50301
